PyInvesting

Market research

G09.F Genomic Vision Société Anonyme

F EUR Healthcare

Latest close

1,017.93 —

As of Nov 19, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
693K
P/E ratio
Not available
Analyst target
Not available
Dividend yield
Not available
Beta
-0.67

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

Genomic Vision Société Anonyme is currently in a long term downtrend where the price is trading 37.3% below its 200 day moving average.

From a valuation standpoint, the stock is 98.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 13.9.

Based on the above factors, Genomic Vision Société Anonyme gets an overall score of 1/5.